These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29894370)

  • 1. Not time to abandon use of local vaginal hormone therapies.
    Pinkerton JV; Kaunitz AM; Manson JE
    Menopause; 2018 Aug; 25(8):855-858. PubMed ID: 29894370
    [No Abstract]   [Full Text] [Related]  

  • 2. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women.
    Goldstein I; Alexander JL
    J Sex Med; 2005 Sep; 2 Suppl 3():154-65. PubMed ID: 16422792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of vaginal estrogens: a systematic review.
    Crandall CJ; Diamant A; Santoro N
    Menopause; 2020 Mar; 27(3):339-360. PubMed ID: 31913230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local oestrogen replacement for local symptoms in older community dwelling women.
    Fonda D
    Gerontology; 1994; 40 Suppl 3():9-13. PubMed ID: 7851802
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of vaginal estrogen in the treatment of urogenital dysfunction in postmenopausal women.
    Bernier F; Jenkins P
    Urol Nurs; 1997 Sep; 17(3):92-5. PubMed ID: 9349043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urogenital aging: solutions in clinical practice.
    Notelovitz M
    Int J Gynaecol Obstet; 1997 Oct; 59 Suppl 1():S35-9. PubMed ID: 9386214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing postmenopausal vaginal atrophy. Vaginal dryness is one of the most irritating symptoms of menopause. Here are some ways to relieve it.
    Harv Womens Health Watch; 2010 Mar; 17(7):4-5. PubMed ID: 20480969
    [No Abstract]   [Full Text] [Related]  

  • 8. Women's preferences toward attributes of local estrogen therapy for the treatment of vaginal atrophy.
    Mattsson LÅ; Ericsson Å; Bøgelund M; Maamari R
    Maturitas; 2013 Mar; 74(3):259-63. PubMed ID: 23312488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study: Replens versus local estrogen in menopausal women.
    Nachtigall LE
    Fertil Steril; 1994 Jan; 61(1):178-80. PubMed ID: 8293835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.
    Al-Baghdadi O; Ewies AA
    Climacteric; 2009 Apr; 12(2):91-105. PubMed ID: 19117185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local estrogen treatment in patients with urogenital symptoms.
    Simunić V; Banović I; Ciglar S; Jeren L; Pavicić Baldani D; Sprem M
    Int J Gynaecol Obstet; 2003 Aug; 82(2):187-97. PubMed ID: 12873780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vulvovaginal complaints.
    Mehta A; Bachmann G
    Clin Obstet Gynecol; 2008 Sep; 51(3):549-55. PubMed ID: 18677149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of estriol in therapy of urogenital disorders in postmenopausal women].
    Perepanova TS; Khazan PL
    Urologiia; 2007; (3):102-4, 107. PubMed ID: 17722629
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaginal Health: Insights, Views & Attitudes (VIVA) - results from an international survey.
    Nappi RE; Kokot-Kierepa M
    Climacteric; 2012 Feb; 15(1):36-44. PubMed ID: 22168244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of local estrogen therapy in the management of pelvic floor disorders.
    Tzur T; Yohai D; Weintraub AY
    Climacteric; 2016 Apr; 19(2):162-71. PubMed ID: 26830033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognizing and treating urogenital atrophy in postmenopausal women.
    Goldstein I
    J Womens Health (Larchmt); 2010 Mar; 19(3):425-32. PubMed ID: 20156082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of local estrogen therapy for urogenital atrophy.
    Archer DF
    Menopause; 2010; 17(1):194-203. PubMed ID: 19602990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urogenital complaints: value of systemic estrogen therapy].
    Hänggi W; Dörflinger A
    Praxis (Bern 1994); 1997 Aug; 86(33):1260-3. PubMed ID: 9381012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genitourinary Syndrome Of Menopause and Vaginal Estrogen Use.
    Steele NM; Ledbetter CA; Bernier F
    Urol Nurs; 2016; 36(2):59-65, 71. PubMed ID: 27281861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A vaginal estradiol softgel capsule, TX-004HR, has negligible to very low systemic absorption of estradiol: Efficacy and pharmacokinetic data review.
    Simon JA; Archer DF; Constantine GD; Pickar JH; Amadio JM; Bernick B; Graham S; Mirkin S
    Maturitas; 2017 May; 99():51-58. PubMed ID: 28364869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.